OPKO HEALTH INC. - COMMON STOCK

OPKO Health Receives U.S. FDA Approval for the 4Kscore® Test

08 Dec 2021 07:00:02 By Nasdaq GlobeNewswire

OPKO Health Announces the Passing of Director Dr. Richard Lerner

06 Dec 2021 07:00:02 By Nasdaq GlobeNewswire

OPKO Health Announces Participation in Piper Sandler 33rd Annual Virtual Healthcare Conference

29 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

OPKO Health Reports 2021 Third Quarter Business Highlights and Financial Results

28 Oct 2021 15:15:01 By Nasdaq GlobeNewswire

OPKO Health to Report Third Quarter 2021 Financial Results on October 28, 2021

25 Oct 2021 09:57:14 By Nasdaq GlobeNewswire

Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency

24 Sep 2021 15:24:07 By Nasdaq GlobeNewswire

LeaderMed Group and OPKO Health Form Joint Venture to Develop and Commercialize Oxyntomodulin and Factor VIIa-CTP in China and Other Asian Territories

14 Sep 2021 07:00:01 By Nasdaq GlobeNewswire

OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients

30 Aug 2021 15:17:19 By Nasdaq GlobeNewswire

OPKO Health to Participate in Two Upcoming Investment Conferences

30 Aug 2021 08:04:49 By Nasdaq GlobeNewswire

OPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results

29 Jul 2021 15:05:01 By Nasdaq GlobeNewswire

OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021

20 Jul 2021 07:00:02 By Nasdaq GlobeNewswire

OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics

12 Jul 2021 07:00:01 By Nasdaq GlobeNewswire

OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference

08 Jul 2021 15:05:00 By Nasdaq GlobeNewswire

OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx

22 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics

21 Jun 2021 07:03:07 By Nasdaq GlobeNewswire

OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland

17 Jun 2021 06:00:00 By Nasdaq GlobeNewswire

OPKO Health to Participate in the Jefferies Virtual Healthcare Conference

27 May 2021 07:30:01 By Nasdaq GlobeNewswire

OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor

24 May 2021 06:30:00 By Nasdaq GlobeNewswire

OPKO Health Enters into Exchange Agreements with Certain 4.5% Convertible Senior Noteholders

07 May 2021 12:33:56 By Nasdaq GlobeNewswire

OPKO Health to Report First Quarter 2021 Financial Results on April 28, 2021

22 Apr 2021 07:00:01 By Nasdaq GlobeNewswire